Welcome to our dedicated page for Applied UV news (Ticker: AUVI), a resource for investors and traders seeking the latest updates and insights on Applied UV stock.
Applied UV, Inc. (AUVI) delivers innovative UV-based disinfection systems and custom mirror solutions for healthcare and hospitality sectors. This page provides investors and industry professionals with direct access to official announcements, financial updates, and strategic developments from the company.
Find timely updates on product launches, regulatory milestones, and partnership agreements that shape AUVI’s position in smart building technology and infection control markets. Content includes earnings reports, technology patents, and market expansion initiatives, offering insights into the company’s operational priorities.
Bookmark this page to stay informed about AUVI’s advancements in automated sterilization systems and decorative mirror designs. Regular updates ensure you never miss critical information affecting the company’s performance across global healthcare and hospitality markets.
Applied UV has completed the acquisition of KES Science & Technology and JJS Technologies for $4.3 million and 300,000 shares. This strategic move enhances their air purification portfolio, leveraging patented technology originally developed for NASA. KES's products are expected to generate $5-7 million in revenue for 2022 and immediately boost earnings per share. The acquisition expands access to markets including food distribution and cannabis, positioning Applied UV for growth in the air purification sector, while consolidating its Airocide brand.
Applied UV (NASDAQ:AUVI) has declared a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock (Nasdaq: AUVIP). This dividend payment is set for October 15, 2021, to shareholders on record by October 4, 2021. The company specializes in infection control technologies, leveraging UVC light and catalytic bioconversion for air purification. Its subsidiaries, SteriLumen and Munn Works, enhance safety in healthcare and commercial environments, addressing critical pathogen threats.
Applied UV has announced the installation of nearly 100 Airocide units in South Korean schools, aimed at enhancing safety as schools reopen amid COVID-19. The company sees potential for further expansion within educational facilities, targeting areas like nurses' rooms and cafeterias. Developed with NASA's technology, Airocide effectively eliminates airborne pathogens and VOCs, ensuring cleaner air for students and staff. This follows previous installations in Uruguay and Switzerland, reflecting the demand for innovative infection control solutions.
Applied UV, Inc. (NASDAQ:AUVI) announced that CEO Q Saeed will present at the virtual H.C. Wainwright Global Investor Conference on September 13, 2021, at 7:00 am EDT. The presentation will focus on the company's innovative infection control technologies utilizing narrow-range ultraviolet light (UVC) and catalytic bioconversion for air purification. Interested viewers can access the presentation on the company's website. Applied UV specializes in solutions for healthcare, hospitality, and other commercial markets to combat pathogens and enhance safety.
Applied UV (NasdaqCM: AUVI) announced on September 8, 2021, that its Vietnam distributor will install Airocide units in Son Tay Hospital and the National Institute of Food Control. This initiative aims to enhance air purification and safeguard patients and staff amidst ongoing health concerns. The Airocide technology, stemming from NASA innovation, employs UVC light for effective pathogen eradication. CEO Q Saeed emphasized the growing international demand for their infection control products as hospitals recognize the system's benefits in communal areas.
Applied UV (NasdaqCM:AUVI) announced a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock, payable on or about September 15, 2021. Holders of record as of September 3, 2021 will receive the payment. The company focuses on infection control technology utilizing UVC light for air purification and surface disinfection, targeting various markets including healthcare and hospitality.
Applied UV (AUVI) announced an 11.1% increase in second-quarter net sales, reaching $1,884,319, attributed to growth in its hospitality subsidiary, MunnWorks. The company raised $13.8 million through a preferred stock offering, strengthening its balance sheet. Despite a net loss of $2,138,232, CEO Q Saeed expressed optimism over future growth, supported by new distribution partnerships and successful pathogen testing of its SteriLumen products against SARS-CoV-2. The company continues to focus on expanding its global presence and enhancing its product efficacy through quality testing.
Applied UV (NASDAQ:AUVI) announced over 100 Airocide® units installed at the U.S. Army's Aberdeen Proving Ground (APG) since 2020 through distributor BATTA Environmental Associates. This partnership aims to enhance infection control and provide cleaner environments for military personnel. The Airocide system utilizes NASA-developed technology to eliminate air pollutants and pathogens. With growing opportunities in U.S. military facilities, Applied UV anticipates expanding its sales in government sectors, further solidifying its market position.
Applied UV announced that its distributor, Cellarius, has installed additional Airocide units in wineries across Greece and Hungary, enhancing air purification to combat mold and pathogens. This latest installation brings the total number of Airocide units in these wineries to nearly 100, contributing to safer environments for staff and visitors. Airocide technology, utilized by over 200 wineries globally, plays a crucial role in preserving wine quality by eliminating harmful microorganisms, thus reducing costly losses for winemakers.
Applied UV, Inc. (NASDAQ:AUVI) announced an investor conference call on August 17, 2021, at 8:30 am EDT to discuss its second quarter financial results. Investors can access the call via a live webcast on the company’s website. A replay will be available for one week post-call. The company focuses on infection control technology using UVC light, targeting healthcare and hospitality sectors. Its subsidiaries include SteriLumen and Munn Works, offering innovative solutions for air and surface purification.
FAQ
What is the current stock price of Applied UV (AUVI)?
What is the market cap of Applied UV (AUVI)?
